EM
Eliana Merle Barclays Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
40
Avg Return
Past Year
Past Year
8.1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
74.3%
Neutral
22.9%
Negative
2.9%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $923 |
50%
upside
| 1 | -0.93% |
0
%
| 6 Mar ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $105 |
89%
upside
| 2 | -2.2% |
0
%
| 4 Mar ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $56 |
29%
upside
| 2 | -18% |
0
%
| 2 Mar ‘26 3 months ago |
|
|
|
Underweight
Downgraded
| $0.3000 |
80%
upside
| 3 | -33% |
0
%
| 24 Feb ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $607 |
35%
upside
| 2 | -0.74% |
0
%
| 17 Feb ‘26 3 months ago |
|
|
|
Equal-Weight
Initiated
| $31 |
11%
upside
| 1 | – |
–
| 28 Jan ‘26 4 months ago |
|
|
|
Overweight
Initiated
| $59 |
107%
upside
| 1 | +19% |
0
%
| 28 Jan ‘26 4 months ago |
|
|
|
Equal-Weight
Initiated
| $8 |
24%
upside
| 1 | +45% |
–
| 28 Jan ‘26 4 months ago |
|
|
|
Overweight
Upgraded
| $119 |
55%
upside
| 1 | -12% |
0
%
| 28 Jan ‘26 4 months ago |
|
|
|
Overweight
Initiated
| $66 |
69%
upside
| 1 | -16% |
0
%
| 28 Jan ‘26 4 months ago |
|
|
|
Overweight
Initiated
| $964 |
93%
upside
| 3 | +13% |
0
%
| 28 Jan ‘26 4 months ago |
|
|
|
Overweight
Initiated
| $18 |
379%
upside
| 1 | -13% |
0
%
| 28 Jan ‘26 4 months ago |
|
|
|
Overweight
Initiated
| $231 |
137%
upside
| 1 | -12% |
0
%
| 28 Jan ‘26 4 months ago |
|
|
|
Overweight
Initiated
| $342 |
53%
upside
| 2 | +11% |
0
%
| 28 Jan ‘26 4 months ago |
|
|
|
Overweight
Initiated
| $33 |
258%
upside
| 1 | 0% |
0
%
| 28 Jan ‘26 4 months ago |
|
|
|
Overweight
Initiated
| $80 |
18%
upside
| 3 | +28% |
0
%
| 28 Jan ‘26 4 months ago |
|
|
|
Equal-Weight
Initiated
| $24 |
42%
downside
| 2 | +21% |
0
%
| 28 Jan ‘26 4 months ago |
|
|
|
Overweight
Initiated
| $527 |
83%
upside
| 3 | +11% |
0
%
| 28 Jan ‘26 4 months ago |
|
|
|
Neutral
Assumed
| $34 |
35%
downside
| 3 | +16% |
0
%
| 7 Jan ‘26 5 months ago |
|
|
|
Buy
Maintained
| $24 |
809%
upside
| 1 | +0.83% |
0
%
| 13 Aug ‘25 10 months ago |
|
|
|
Neutral
Maintained
| $9 |
84%
downside
| 2 | – |
–
| 12 Aug ‘25 10 months ago |
|
|
|
Neutral
Maintained
| $20 |
66%
downside
| 1 | – |
–
| 12 Aug ‘25 10 months ago |
|
|
|
Neutral
Downgraded
| $12 |
24%
downside
| 1 | – |
–
| 21 Jul ‘25 10 months ago |
|
|
|
Buy
Maintained
| $8 |
379%
upside
| 1 | -41% |
0
%
| 15 Jul ‘25 11 months ago |
|
|
|
Neutral
Downgraded
| $5.50 |
18%
upside
| 2 | +54% |
0
%
| 26 Jun ‘25 11 months ago |
|